Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Consylman Gina, Chief Financial Officer. Insider active across 1 company, notably bluebird bio, Inc.. Cumulatively, 2 reports have been logged. Activity tracked since 11 November 2021. The latest transaction was disclosed on 1 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Gina Consylman is the Chief Financial Officer of bluebird bio, Inc. She is responsible for the company's financial management, including financial planning, reporting, and overall financial strategy. With expertise in finance, she plays a key role in strategic decision-making to support the company's growth and sustainability.